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Abstract
Background: Basidiobolomycosis is a rare disease caused by the fungus Basidiobolus ranarum, member of
the class Zygomycetes, order Entomophthorales, found worldwide. Usually basidiobolomycosis is a
subcutaneous infection but rarely gastrointestinal manifestations have been described; 13 adults and 10
children and a few retroperitoneal or pulmonary cases. In gastrointestinal basidiobolomycosis the colon is
most frequently involved, usually presenting with subacute mild abdominal pain. In contrast to children
only very few described adult patients had hepatic masses. Definitive diagnosis requires culture, serological
testing can be helpful. The fungal morphology and the Splendore-Hoeppli phenomenon are characteristic
histological features. There are no prominent risk factors. Usually surgery and prolonged antifungal
therapy are required.
Case presentation: A 61 year old man presented with progressive left abdominal pain and constipation
since a few months. Colonoscopy showed an obstructing tumour in the descending colon, and a
hemicolectomy was performed. Histology showed inflammation, possibly caused by a fungal or parasitic
infection, without definite identification of an organism. A few weeks postoperatively a CT scan made
because of abdominal discomfort, revealed a livermass (6 cm). Treatment with metronidazole, directed
against an amoebic liver abscess, was unsuccessful. He developed a marked eosinophilia (27.7%). A liver
biopsy was performed and the patient was referred to a university hospital.
A repeated CT scan showed a livermass of 9 cm diameter. Review of colon and liver biopsy samples
showed extensive necrosis and histiocytes, multinucleated giant cells and numerous eosinophils. Grocott
stained sections contained unusually large hyphae surrounded by strongly eosinophilic material in
haematoxylin and eosin stained sections (Splendore-Hoeppli phenomenon). A presumptive diagnosis of
Basidiobolus spp. infection was made and treated with amphotericin B (Itraconazol contra-indicated
because of renal insufficiency). A few days later the patient died of a septic shock. After autopsy Basidiobolus
ranarum was cultured from liver, gallbladder and colon.
Conclusion: Our patient died of gastrointestinal basidiobolomycosis with an obstructing colon tumour
and a large hepatic mass. This was a rare presentation of basidiobolomycosis and the second fatal case
described worldwide.
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Basidiobolomycosis is a rare disease caused by the fungus
Basidiobolus ranarum, an environmental saprophyte, mem-
ber of the class Zygomycetes, order Entomophthorales, found
worldwide [1]. Usually basidiobolomycosis is a subcuta-
neous infection that is transmitted through traumatic
inoculation [1]. Gastrointestinal basidiobolomycosis is
rare with only 13 cases reported worldwide in adults [2,3]
and 10 in children. [4,5]. Only a few cases of retroperito-
neal [6-8] or pulmonary [9] basidiobolomycosis have
been reported. In gastrointestinal basidiobolomycosis the
colon is the most frequently involved part of the gastroin-
testinal tract, and patients usually present with mild
abdominal pain with a subacute onset, eosinophilia, and
on histopatologic examination inflammatory changes
with many eosinophils [2]. In contrast to pediatric
patients only very few of the reported adult patients also
had a hepatic mass [4,5,10]. Definitive diagnosis requires
culture of the organism, serological testing via an immun-
odiffusion method can be helpful [1]. Because a fungal
infection is not always suspected, in a number of patients
the diagnosis must be made on histology alone. The fun-
gal morphology and the Splendore-Hoeppli phenome-
non, although not entirely specific, are characteristic
histological features.
There are no prominent risk factors for this disease [2]. For
treatment surgery is usually required, followed by pro-
longed antifungal therapy [1,2]. The preferred drug is itra-
conazole [2].
Case presentation
A 61 year old man presented with progressive lower left
abdominal pain and constipation since a few months.
Colonoscopy showed a large obstructing tumour in the
descending colon, and a hemicolectomy was performed.
Histology showed an inflammatory reaction, possibly
caused by a fungal or parasitic infection, but no definite
identification of an organism was made. Postoperatively
his complaints disappeared, but after a few weeks he
developed abdominal discomfort in his right upper abdo-
men, and six weeks postoperatively a CT scan revealed a
large mass with a diameter of 6 cm central in the right liver
lobe. Treatment with metronidazole, directed against an
amoebic liver abscess, was unsuccessful. A subsequent
four-week course with fluconazole resulted in a small
decrease of the liver abscess, without clinical improve-
ment. He developed a marked eosinophilia (27.7%). A
liver biopsy was performed and the patient was referred to
a university hospital.
A repeated CT scan showed a large mass with a diameter
of 9 cm central in the liver, with extension to the right liver
lobe (figure 1A). Review of the slides from the colonic
mass and the liver biopsy showed similar features, with
extensive necrosis and a mixed inflammatory cell infiltrate
containing histiocytes, multinucleated giant cells and
numerous eosinophils. In Grocott stained sections, many
unusually large hyphae could be recognized which were
surrounded by strongly eosinophilic material in haema-
toxylin and eosin stained sections (Splendore-Hoeppli
phenomenon) (figure 2).
On the basis of this morphology, a presumptive diagnosis
of infection with Basidiobolus spp. was made. A percutane-
ous cholangiodrain was placed to treat the cholestasis
caused by the hepatic mass. A few days later, the patient
developed a septic shock, probably of hepatic origin.
Blood cultures yielded Escherichia coli and Clostridium per-
fringens. The patient was treated with broad-spectrum
antibiotics. The presumed basidiobolomycosis was
treated with amphotericin B intravenously, because the
preferred therapy, intravenous itraconazole, was contra-
indicated because of severe renal insufficiency. A few days
after initiation of the antifungal therapy the patient died
of multiple organ failure. Postmortem autopsy showed
signs of extensive fungal infection of the liver (figure 1B),
gallbladder and sigmoid colon. Culture of liver, gallblad-
der and sigmoid colon yielded Basidiobolus ranarum.
Conclusion
Our patient died of gastrointestinal basidiobolomycosis
with an obstructing colon tumour and a large hepatic
mass. There was difficulty in reaching the diagnosis. The
case provides a teaching point, because although gastroin-
testinal basidiobolomycosis is a rare disease, the clinical
presentation of our patient was characteristic for this dis-
ease. The prognosis of gastrointestinal basidiobolomyco-
sis is usually favourable, our patient is the second in
whom the outcome was fatal [9]. Better familiarity with
this condition may prevent a fatal outcome like in our
patient
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A. CT scan of the abdomen showing a large mass central in the liver, with extension to the right liver lobeFigure 1
A. CT scan of the abdomen showing a large mass central in the liver, with extension to the right liver lobe. B. Postmortem 
aspect of the liver, with extensive fungal infection.
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Liver biopsy, showing large hyphae surrounded by strongly eosinophilic material and an inflammatory cell infiltrate containing 
histiocytes, multinucleated giant cells and numerous eosinophils. (a) H&E stained (b) Grocott stained sections.Page 3 of 4
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